Pancreatic Cancer Research

ResearcherMassachusetts Institute of TechnologyActive in the last 2 years

Peter M.K. Westcott

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9436-4857; OpenAlex author ID A5004108376. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
1
Collaborators
8
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 3

  1. A PanIN-oramic view of early pancreatic cancer in 3D. Last author DOI 10.1016/j.it.2026.05.007↗
  2. Personalized syringes offer hope for pancreatic cancer patients. First author DOI 10.1016/j.immuni.2025.04.026↗
  3. The CD155/TIGIT axis promotes and maintains immune evasion in neoantigen-expressing pancreatic cancer. Co-author DOI 10.1016/j.ccell.2021.07.007↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Longling S. Shui · 1 shared paper, 2025 · strength 0.54
  2. Alexander Cicala · 1 shared paper, 2026 · strength 0.50
  3. William L. Hwang · 1 shared paper, 2021 · strength 0.10
  4. Zackery A. Ely · 1 shared paper, 2021 · strength 0.10
  5. William A. Freed-Pastor · 1 shared paper, 2021 · strength 0.10
  6. Aviv Regev · 1 shared paper, 2021 · strength 0.10
  7. Vikram Deshpande · 1 shared paper, 2021 · strength 0.10
  8. Tyler Jacks · 1 shared paper, 2021 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.